Free Trial
ETR:SHL

Siemens Healthineers (SHL) Stock Price, News & Analysis

Siemens Healthineers logo
€43.95 +0.15 (+0.34%)
As of 11/13/2026

About Siemens Healthineers Stock (ETR:SHL)

Advanced

Key Stats

Today's Range
€43.32
▼
€44.15
50-Day Range
€37.20
▼
€45.00
52-Week Range
€45.51
▼
€58.14
Volume
781,249 shs
Average Volume
N/A
Market Capitalization
€49.59 billion
P/E Ratio
25.55
Dividend Yield
2.28%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers worldwide. It operates through four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment provides magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound systems. Its Diagnostics segment offers in-vitro diagnostic products and services to healthcare providers in laboratory and point-of-care diagnostics; and workflow solutions for laboratories and informatics products. The Varian segment provides cancer care technologies, solutions, and services to oncology departments in hospitals and clinics; and technology-enabled optimized workflows, clinical services, and digital solutions and applications for managing treatment and therapy. Its Advanced Therapies segment offers products that are designed to support image-guided minimally invasive treatments in various areas, such as cardiology, interventional radiology, and surgery; and angiography systems and mobile C-arms. It offers essential technical customer service, such as maintenance and repair; medical equipment performance management; training; clinical education and e-learning; planning and design; financing; asset management; and managed departmental services for laboratories and healthcare facilities, as well as digital healthhcare consulting, products, and services. The company is headquartered in Forchheim, Germany. Siemens Healthineers AG operates as a subsidiary of Siemens Aktiengesellschaft.

Receive SHL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Siemens Healthineers and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

SHL Stock News Headlines

Is Siemens Healthineers (XTRA:SHL) Undervalued As It Plans Its Spin Off?
Today's free pick (on me)
Elon Musk doesn't own the chip inside every Tesla, Starlink dish, and AI satellite - he licenses it from one lesser known company. With plans filed for 1,000,000 new satellites, that licensing fee could scale dramatically. Analyst Dylan says the stock could move by December 8th.tc pixel
Siemens Healthineers Earnings Call Balances Growth and Costs
Siemens Healthineers AG : Barclays reiterates its Buy rating
Siemens Healthineers AG : Deutsche Bank gives a Neutral rating
See More Headlines

SHL Stock Analysis - Frequently Asked Questions

Siemens Healthineers' stock was trading at €44.92 at the start of the year. Since then, SHL stock has decreased by 2.2% and is now trading at €43.95.

Based on aggregate information from My MarketBeat watchlists, some other companies that Siemens Healthineers investors own include Bristol Myers Squibb (BMY), Danaher (DHR), GE Aerospace (GE), Merck & Co., Inc. (MRK), Boston Scientific (BSX), MorphoSys (MOR) and Adobe (ADBE).

Industry, Sector and Symbol

Stock Exchange
ETR
Industry
Healthcare Equipment & Supplies
Sub-Industry
N/A
Current Symbol
ETR:SHL
CIK
N/A
Fax
N/A
Employees
74,300
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
€1.72
Trailing P/E Ratio
25.55
Forward P/E Ratio
N/A
P/E Growth
1.16
Net Income
€1.96 billion
Net Margins
9.37%
Pretax Margin
N/A
Return on Equity
11.72%
Return on Assets
3.69%

Debt

Debt-to-Equity Ratio
74.27
Current Ratio
1.18
Quick Ratio
0.71

Sales & Book Value

Annual Sales
€23.88 billion
Price / Sales
2.08
Cash Flow
€1.13 per share
Price / Cash Flow
38.96
Book Value
€17.92 per share
Price / Book
2.45

Miscellaneous

Outstanding Shares
1,128,264,877
Free Float
N/A
Market Cap
€49.59 billion
Optionable
Not Optionable
Beta
0.84
7 Energy Stocks to Buy and Hold Forever Cover

Oil still powers the global economy, but AI is reshaping the energy opportunity. Discover seven stocks spanning traditional energy, infrastructure, and next-generation power.

Get This Free Report

This page (ETR:SHL) was last updated on 11/13/2026 by MarketBeat.com Staff.
From Our Partners